A Multi-institutional Assessment of Multimodal Analgesia in Penile Implant Recipients Demonstrates Dramatic Reduction in Pain Scores and Narcotic Usage
- 19 December 2019
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 17 (3) , 518-525
Abstract
Introduction: Despite the pain associated with inflatable penile prosthesis (IPP) implantation, there has been a lack of standardized, nonopioid pain control regimens described to date. Aim: To assess the effectiveness of a multimodal analgesic regimen in patients undergoing implantation of an IPP compared with patients treated with an opioid-only regimen. Methods: A large, multicenter patient cohort undergoing IPP implantation whose pain was managed using a multimodal analgesia (MMA) protocol (preoperative and postoperative acetaminophen, meloxicam orcelecoxib, and gabapentin and intraoperative dorsal and pudendal nerve blocks) was compared with a matched cohort of patients managed via an opioid-only protocol. Both groups were compared with respect to visual analog score (VAS) and opioid usage (total morphine equivalents [TME]) in the post-anesthesia care unit (PACU), postoperative day 0 (POD0) and postoperative day 1 (POD1), and in the immediate postdischarge period. Narcotic usage on discharge and follow-up were assessed and compared. Main Outcome Measure: Postoperative pain scores and narcotic usage are the main outcome measures. Results: 203 patients were eligible for final analysis: 103 (50.7%) patients receiving MMA medication and 100 (49.3%) patients receiving opioids only. The VAS was significantly lower in the multimodal group in PACU (median 0.0 vs 2.0, P = .001), POD0 (median 3.0 vs 4.0, P = .001), and POD1 (median 3.0 vs 4.3, P = .04). Patients in the multimodal group also used fewer narcotics in PACU (median 0.0 vs 4.0 TME, P = .001), POD0 (median 7.5 vs 12.5 TME, P < .001), and POD1 (median 7.5 vs 13.5 TME, P = .01). Despite being discharged with fewer narcotics (median 20.0 vs 30.0 tablets, P < .001), a smaller proportion of patients in the MMA cohort required narcotic refills (10.7% vs 28.0%, P = .001). There were no narcotic- or MMA medication–related side effects in the entire cohort. Clinical Implications: MMA confers significant improvement in pain management while also providing a significant reduction in narcotic usage in patients undergoing implantation of IPP. Strength & Limitations: This is the 1st large multi-institutional assessment of a multimodal analgesic regimen in urologic prosthetic surgery. The analgesic regimen targets several pain pathways that provide excellent pain control throughout the recovery process. Limitations include retrospective design and lack of standardization of the nonsteroidal anti-inflammatory drug type within the multimodal analgesic regimen. Conclusion: The use of a MMA protocol significantly reduces postoperative pain measures in penile implant recipients and further reduces both inpatient and outpatient narcotic usage without any discernable side effects.Keywords
This publication has 20 references indexed in Scilit:
- Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015MMWR. Morbidity and Mortality Weekly Report, 2017
- Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled TrialThe Journal of Arthroplasty, 2017
- Medication Sharing, Storage, and Disposal Practices for Opioid Medications Among US AdultsJAMA Internal Medicine, 2016
- Current Strategies in Anesthesia and Analgesia for Total Knee ArthroplastyJournal of the American Academy of Orthopaedic Surgeons, 2016
- Long-acting liposomal bupivacaine decreases inpatient narcotic requirements in men undergoing penile prosthesis implantationUrology Research and Practice, 2016
- Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trialJournal of Cardiothoracic Surgery, 2014
- Long-term Analgesic Use After Low-Risk SurgeryArchives of internal medicine (1960), 2012
- A Comparison of Regularly Administered Sustained Release Oral Morphine with Intramuscular Morphine for Control of Postoperative PainAnesthesia & Analgesia, 2000
- Adverse Drug Events in Hospitalized PatientsExcess Length of Stay, Extra Costs, and Attributable MortalityJAMA, 1997
- The Costs of Adverse Drug Events in Hospitalized PatientsJAMA, 1997